- Filed
- Nov 1, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Oct 28, 2024 | 9.35M sh |
| Short Term Investments | Q1 2025 · Sep 30, 2024 | $9.14M |
| Short Term Investments | Q1 2025 · Jun 30, 2024 | $12.1M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $2.75M |
| Cash And Equivalents | Q1 2025 · Jun 30, 2024 | $2.84M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $2.36M |
| Current Liabilities | Q1 2025 · Jun 30, 2024 | $1.3M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $7.25M |
| Total Liabilities | Q1 2025 · Jun 30, 2024 | $6.05M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $19.34M |
| Current Assets | Q1 2025 · Jun 30, 2024 | $21.92M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $38.1M |
| Total Assets | Q1 2025 · Jun 30, 2024 | $37.2M |
| Shares Diluted | Q1 2025 · Sep 30, 2023 | 9.23M sh |
| Capex | Q1 2025 · Sep 30, 2023 | $312.72K |
| Operating Cash Flow | Q1 2025 · Sep 30, 2023 | −$713.25K |
| Stockholders Equity restated | Q1 2025 · Sep 30, 2023 | $31.6M |
| Stockholders Equity restated | Q1 2025 · Jun 30, 2023 | $31.81M |
| Eps Diluted | Q1 2025 · Sep 30, 2023 | −$0.03 |
| Eps Basic | Q1 2025 · Sep 30, 2023 | −$0.03 |
| Sga Expense | Q1 2025 · Sep 30, 2023 | $1.54M |
| Net Income | Q1 2025 · Sep 30, 2023 | −$257.61K |
| Operating Income | Q1 2025 · Sep 30, 2023 | −$468.59K |
| Gross Profit | Q1 2025 · Sep 30, 2023 | $1.07M |
| Cost Of Revenue | Q1 2025 · Sep 30, 2023 | $2.31M |